AtaGenix

Hot search： CD47 │ IL6 │ PD-L1 │ CTLA-4 │ TIGIT
Current Site： Product Center / 2019-nCoV products / 2019-nCoV Antibody / Anti 2019-nCoV South Africa spike variant Neutralizing antibody(B.1.351)

Anti 2019-nCoV South Africa spike variant Neutralizing antibody(B.1.351)

  • 1
  • 2
ATMA10330Mo
-
+
Spot
Inquiry
  • Product Details
  • How to order
  • Instructions
Summaryicon
Product name
Anti 2019-nCoV South Africa spike variant Neutralizing antibody(B.1.351)
description
Recombinant anti SARS-CoV-2(2019-nCoV) South Africa spike variant Neutralizing antibody(B.1.351) is expressed from XtenCHO
Alternative names
Anti Spike glycoprotein antibody
Stability &Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles.
Store at 2 to 8 °C for one week .
Store at -20 to -80 °C for twelve months from the date of receipt.
Spcificity
Recognizes SARS-CoV-2(2019-nCoV) South Africa spike variant Protein
Isotype
Human IgG
Clonality
Monoclonal
Conjugation
Unconjugated
Species reactivity
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Tested applications
WB,ELISA
Immunogen
Recombinant SARS-CoV-2(2019-nCoV) South Africa spike variant protein
SDS-PAGE imageicon
    Bioactivityicon
      Product performanceicon
      Form
      Liquid
      Buffer
      PBS,pH7.5
      Applicationicon
      Dilution Range
      WB:1:1000-2000; ELISA:1:5000-1:10000
      Noteicon
      For research use only .Not for use in clinical diagnostic procedures.

      Guarantee and Disclaimer:

      After receiving the product, if finds that the product is mismatched, damaged or missing components, please keep the original package and submit the objection to the company by mail within seven working days. Failure to file an objection within the time limit is considered qualified.

      When the buyer keeps the product, it should be kept in accordance with the storage conditions shown in the product label and the manual. If the product quality is caused by improper storage, it will not be guaranteed.

      When the buyer tests the product, they should be submitted by the beginning of use when found the quality issue, rather than when the product was used or used up, in order to prepare our products for recycling and confirm the quality of the products. If it is the quality problem, our company is responsible for exchange or return. In the event of a claim, our company will compensate the discretion within the scope of the product price limit and will not accept any part of the value of the product itself. Since the date of receipt, the product has not been reflected for more than three months and should not be returned.

      The products provided by our company are for research use only and should not be used for clinical diagnosis or treatment. If a unit or individual changes the use of our products without authorization, we will not bear any responsibility.

      AtaGenix
      Copyright © 2024 Lawyer Theme All Rights Reserved
      Site map | Contact us | Join us